Celcuity is a clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated companion diagnostic (CDx) and therapeutic (Rx) strategy that leverages the CELsignia CDx platform.

Biotechnology

Celcuity

Celcuity's headquarters in Minneapolis, MN, United States

Brian Sullivan

Igor Gorbatchevsky

Vicky Hahne

Eldon Mayer

Brent Eilefson

Lisa Rautenberg

Lance Laing

Ben Ho Park

Carol Lange

Edward Greeno

Richard Buller

David F. Dalvey

Manfred Auer

Adam Brufsky

Sara Hurvitz

Benita Katzenellenbogen

John Katzenellengogen

Hung Khong

Bora Lim

Alberto Montero

Mark Pegram

Mothaffar F. Rimawi

Stanley Marks

Polly Murphy

Ron McGlennen

Leo Furcht

Richard J. Nigon

Lee S. Schwartzberg

The Scientific Advisors team at Celcuity provides expert guidance on clinical and research strategies to advance the development of the CELsignia CDx platform and associated cancer therapies, ensuring scientific rigor and innovation in extending patient lives.

Scientific Advisors

This department oversees the planning, execution, and management of clinical trials and related activities in pharmaceutical development.

Clinical Development

This department focuses on driving growth and strategic partnerships across various regions.

Business Development

The Leadership Team at Celcuity is responsible for steering the company's strategic vision and operational execution. Comprising experts in pharmaceutical development, research, quality assurance, and finance, the team collaborates to advance Celcuity's mission of developing innovative diagnostic and therapeutic solutions for cancer patients. Their leadership ensures alignment across departments, fosters innovation, and drives the progression of clinical initiatives to enhance patient outcomes.

Leadership Team

This department focuses on driving customer engagement through data analysis and strategic marketing initiatives.

Engagement and Insights

The Scientific Research Team at Celcuity conducts advanced research to develop and validate companion diagnostics (CDx) using the CELsignia platform. They focus on identifying biomarkers and therapeutic targets to optimize cancer treatment strategies, working collaboratively to support the clinical development and regulatory approval of new diagnostic and therapeutic products.

Scientific Research Team

Celcuity

Org chart

Board & advisors

Teams

Scientific Advisors

Clinical Development

Business Development

Leadership Team

Engagement and Insights

Scientific Research Team

Offices

Celcuity

Org chart

Board & advisors

Teams

Scientific Advisors

Clinical Development

Business Development

Leadership Team

Engagement and Insights

Scientific Research Team

Offices

Related companies